Ginkgo Bioworks Holdings Inc vs iShares MSCI South Korea ETF — how do they compare? Ginkgo Bioworks Holdings Inc trades at $7.29 (market cap $505.73M), while iShares MSCI South Korea ETF trades at $175.1. The key difference: iShares MSCI South Korea ETF is trading nearer its 52-week high, Ginkgo Bioworks Holdings Inc nearer its low. Which is the better fit depends on your goals.
| DNA | EWY | |
|---|---|---|
Market Cap | $505.73M | — |
Sector | Health | Broad Market / Factor |
52-Week High | $16.14 | $219.20 |
52-Week Low | $5.48 | $71.22 |
Enterprise Value | $607.68M | — |
Trailing returns across standard periods
Ginkgo Bioworks is a leading horizontal platform for cell programming. It uses advanced automation and software to design custom organisms for customers across diverse industries, including food, agriculture, and pharma.
Read more on DNA →EWY tracks the MSCI Korea 25/50 Index, offering targeted exposure to large and mid-cap companies in South Korea. It is structurally centered on the global technology supply chain, industrials, and financial services, serving as a liquid tool for investors seeking a single-country view of this advanced, innovation-led economy.
Read more on EWY →